Koltai M Z, Rösen P, Hadházy P, Ballagi-Pordány G, Köszeghy A, Pogátsa G
National Institute of Cardiology, Department of Pharmacodynamics, Semmelweis Medical School, Budapest, Hungary.
J Diabet Complications. 1988 Jan-Mar;2(1):5-7. doi: 10.1016/0891-6632(88)90017-7.
Before the onset of histologically detectable alterations in diabetic arteries, a considerable decrease in vasodilatory potential is seen. While analyzing this phenomenon, the role of altered PGI2 synthesis in rings of coronary arteries from metabolically healthy and alloxan-diabetic dogs was measured by radioimmunoassay during baseline, under the influence of phenylephrine (100 mumol/L), and during hypoxia with or without the presence of the alpha adrenergic blocker phentolamine (5 mumol/L). Basal levels of PGI2 synthetized by healthy and diabetic coronaries were no different (7.9 +/- 2.1 and 6.4 +/- 1.4 pg/mg vessel). Phenylephrine potentiated PGI2 synthesis in controls (150 +/- 22%), while it proved to be ineffective in the diabetic animals (98 +/- 6%). Under hypoxic conditions, PGI2 production of healthy coronaries (152 +/- 24%) increased, while that in the diabetic ones (82 +/- 7%) decreased (p less than 0.01). In the presence of phentolamine no difference could be detected between the two groups. Given all these data, the decreased ability of the diabetic coronaries to vasodilate develops due to diminished PGI2 production, presumably controlled by adrenergic mechanisms. Furthermore, the more severe outcome of ischaemic heart disease in diabetes mellitus might be explained by the lack of an enhanced coronary PGI2 synthesis under hypoxic conditions.
在糖尿病动脉出现组织学可检测到的改变之前,血管舒张潜能就已出现显著下降。在分析这一现象时,通过放射免疫分析法测定了代谢健康和四氧嘧啶诱导糖尿病犬冠状动脉环中PGI2合成改变的作用,测定过程包括基线期、在去氧肾上腺素(100 μmol/L)影响下以及在有或无α肾上腺素能阻滞剂酚妥拉明(5 μmol/L)存在的低氧条件下。健康和糖尿病冠状动脉合成的PGI2基础水平无差异(分别为7.9±2.1和6.4±1.4 pg/mg血管)。去氧肾上腺素使对照组的PGI2合成增强(150±22%),而在糖尿病动物中却无效(98±6%)。在低氧条件下,健康冠状动脉的PGI2生成增加(152±24%),而糖尿病冠状动脉的PGI2生成减少(82±7%)(p<0.01)。在酚妥拉明存在的情况下,两组之间未检测到差异。综合所有这些数据,糖尿病冠状动脉舒张能力下降是由于PGI2生成减少所致,推测是由肾上腺素能机制控制的。此外,糖尿病患者缺血性心脏病更严重的后果可能是由于在低氧条件下冠状动脉PGI2合成缺乏增强所致。